In vivo fate of lipid-based nanoparticles-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In vivo fate of lipid-based nanoparticles

Published:2017-01 Issue:1 Volume:22 Page:166-172
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Qi Jianping,Zhuang Jie,Lu Yi,Dong Xiaochun,Zhao Weili,Wu Wei

Funder

Shanghai Commission of Science and Technology

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference60 articles.

1. 50 years of oral lipid-based formulations: provenance, progress and future perspectives;Feeney;Adv. Drug Deliv. Rev.,2016

2. Lipid-calcium phosphate nanoparticles for delivery to the lymphatic system and SPECT/CT imaging of lymph node metastases;Tseng;Biomaterials,2014

3. A copper-mediated disulfiram-loaded pH-triggered PEG-shedding TAT peptide-modified lipid nanocapsules for use in tumor therapy;Zhang;ACS Appl. Mater. Interfaces,2015

4. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier;Beloqui;J. Control. Release,2013

5. The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats;Zhang;Int. J. Pharm.,2010

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gelatin and lipidoid integrate to create gelasomes to enhance siRNA delivery with low toxicity;Bioactive Materials;2024-10

2. Transepithelial transport of nanoparticles in oral drug delivery: From the perspective of surface and holistic property modulation;Acta Pharmaceutica Sinica B;2024-09

3. A Review: Surface Engineering of Lipid‐Based Drug Delivery Systems;Small;2024-07-14

4. Vesicular drug delivery systems for oral absorption enhancement;CHINESE CHEM LETT;2024

5. In vivo Fate of Targeted Drug Delivery Carriers;International Journal of Nanomedicine;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3